Drug GSK5764227 for metastatic colorectal cancer (223675) - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
[223675] A Phase1b/2, multicenter, randomized, open-label study to evaluate the efficacy and safety of GSK5764227 alone and in combination in participants with previously treated advanced unresectable or metastatic gastrointestinal solid tumors
Principal Investigator
Nicholas C. DeVito, MD
Medical Oncologist
Protocol Number
IRB:
PRO00118141
NCT:
NCT06885034
Phase
Phase
I/II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Call 919-668-1861
or email gi-oncology-cru@dm.duke.edu